Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 181121 | AZD-5904 | 618913-30-7 | ≧98.0% |  |
| AZD5904 is a potent orally bioavailable MPO inhibitor. In preclinical studies, AZD590 | ||||
| 171454 | 1-(4-Bromo-6- methylpyridin-2- yl)ethan-1-one | 1060810-24-3 | ≧98.0% |  |
| 1-(4-Bromo-6- methylpyridin-2- yl)ethan-1-one, CAS 1060810-24-3. | ||||
| 20471 | FHD-286 | 2671128-05-3 | ≧98.0% |  |
| FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
| 184163 | 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile | 1032570-98-1 | >96% |  |
| 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile is a drug intermediate. | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK | ||||
| 237071 | Flavopiridol ( Alvocidib ) | 146426-40-6 | ≧98.0% | .png) |
| Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst | ||||
| 20266 | Linzagolix | 935283-04-8 | ≧98.0% |  |
| Linzagolix is a novel, orally administered GnRH receptor antagonist that potentially | ||||
| 20510 | CC-92480 ( Mezigdomide ) | 2259648-80-9 | ≧98.0% |  |
| CC-92480 Is a Novel Cereblon E3 Ligase Modulator with Enhanced Tumoricidal and Immuno | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 51802 | TIC10 ( ONC201 ) | 1616632-77-9 | 99.85% |  |
| TIC10 ( ONC201 ), Bulk in stock, contact us by email for detailed quotation.ONC201/TI | ||||
| 23122601 | Navacaprant ( BTRX-335140 ) | 2244614-14-8 | ≧98.0% | _2244614-14-8.png) |
| Navacaprant (NMRA-335140, BTRX-140) is an oral, selective, reversible, small-molecule | ||||
| 20509 | GLPG3667 | 2308520-97-8 | ≧98.0% |  |
| GLPG3667 is an oral potent and selective small-molecule TYK2 inhibitor in development | ||||